Article

B+L secures agreement for 3D surgical navigation technology

Bausch + Lomb has entered into an exclusive license agreement for a 3-dimensional (3D) surgical navigation technology-the Cirle Surgical Navigation System-from Cirle, Inc., a medical technology incubator based in Miami, FL.

 

Bridgewater, NJ-Bausch + Lomb has entered into an exclusive license agreement for a 3-dimensional (3D) surgical navigation technology-the Cirle Surgical Navigation System-from Cirle, Inc., a medical technology incubator based in Miami, FL.

Bausch + Lomb has agreed to license the system from Cirle to pursue commercialization for cataract surgery.

“Bausch + Lomb is immensely proud to have an opportunity to partner with Cirle on the commercialization of this exciting technology,” said Cal Roberts, MD, chief medical officer, Bausch + Lomb. “The (technology) will be an important addition to ophthalmic operating rooms, which we believe will help us obtain a leading position in this market category.”

Bausch + Lomb announced its partnership with Cirle in late 2012.

“It’s very exciting to see how rapidly this technology has reached this stage of development, a testament to the productivity of industry-incubator collaborations like the unique partnership we have with Bausch + Lomb today,” said Richard Awdeh, MD, found and chief executive officer of Cirle.

 

The surgical navigation technology is not currently commercially available in the United States.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.